HCID 67096156, Verbindung → HCID 57780686, Verbindung
Reaktionsgleichung
CN(C)[CH:3]=[C:4]1[CH2:9][CH2:8][CH2:7][CH:6]([O:10][CH2:11][CH3:12])[C:5]1=O.[N+]([O-])(O)=O.[N+]([O-])(O)=O.[CH3:23][O:24][C:25]1[CH:26]=[C:27]([NH:37][C:38]([NH2:40])=[NH:39])[CH:28]=[CH:29][C:30]=1[N:31]1[CH:35]=[C:34]([CH3:36])[N:33]=[CH:32]1>>[CH2:11]([O:10][CH:6]1[C:5]2[N:40]=[C:38]([NH:37][C:27]3[CH:28]=[CH:29][C:30]([N:31]4[CH:35]=[C:34]([CH3:36])[N:33]=[CH:32]4)=[C:25]([O:24][CH3:23])[CH:26]=3)[N:39]=[CH:3][C:4]=2[CH2:9][CH2:8][CH2:7]1)[CH3:12]Komponenten
3
Versuchsvorschrift
The title compound was prepared from 2-[1-dimethylamino-methylidene]-6-ethoxy-cyclohexanone (232 mg, 1.0 mmol) and N-[3-methoxy-4-(4-methyl-imidazol-1-yl)-phenyl]-guanidine dinitrate (223 mg, 0.60 mmol) using in analogous manner the procedure described in example 45b). Obtained as a white solid (50 mg, 22%). MS ISP (m/e): 380.4 (100) [(M+H)+].
Quellen und Nachweise
- ORD-Eintrag
- ord-492c7c7de17f4693a6165b3b3c05f5f2
- Quelldatensatz
- uspto-grants-2011_04